Genzyme Puts Up $22M To Settle FCA Claims
Genzyme Corp. has agreed to pay more than $22 million to resolve former employees' False Claims Act allegations that it marketed its Seprafilm adhesion barrier for unapproved uses, according to court...To view the full article, register now.
Already a subscriber? Click here to view full article